| NCT ID | NCT06870552 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of South Carolina |
| Condition | Lexical Access in Neurotypicals |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2024-04-23 |
| Primary Completion | 2025-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2024-04-23 with a primary completion date of 2025-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study examines the time course of activation of the left anterior temporal lobe (ATL) during lexical processing using Transcranial Magnetic Stimulation (TMS).
Eligibility Criteria
Inclusion Criteria: * Participants must be within the ages of 18 to 40 * Native speakers of English Exclusion Criteria: * Potential participants with a clinically reported history of dementia, alcohol abuse, psychiatric or neurological disorders, traumatic brain injury, or extensive vision or hearing problems that prevents them from performing the tasks * Contraindication to TMS, determined by a standard TMS screening form * Contraindication to MRI, determined by a standard MRI screening form * Left handed participants
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06870552 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Lexical Access in Neurotypicals. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06870552 currently recruiting?
Yes, NCT06870552 is actively recruiting participants. Contact the research team at rutvik@sc.edu for enrollment information.
Where is the NCT06870552 trial being conducted?
This trial is being conducted at Columbia, United States.
Who is sponsoring the NCT06870552 clinical trial?
NCT06870552 is sponsored by University of South Carolina. The trial plans to enroll 36 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.